| |
Latest 10 SEC filings (by transaction date) for KALV within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Mar 8/24 | Mar 6/24 | Palleiko Benjamin L | Direct Ownership | Restricted Stock Unit | A - Grant, award or other under Rule 16b-3(d) | 250,000 | |
Feb 22/24 | Feb 20/24 | Venrock Healthcare Capital Partners III, L.P. | Indirect Ownership | Pre-Funded Warrants (Right to Buy) | P - Open market or private purchase | 655,738 | $15.25 |
Feb 21/24 | Feb 20/24 | Feener Edward P. | Direct Ownership | Common Stock | S - Open market or private sale | -300 | $14.72 |
Feb 21/24 | Feb 20/24 | Feener Edward P. | Direct Ownership | Common Stock | S - Open market or private sale | -19,591 | $14.04 |
Feb 21/24 | Feb 20/24 | Feener Edward P. | Direct Ownership | Common Stock | S - Open market or private sale | -8,397 | $14.11 |
Feb 21/24 | Feb 20/24 | Yea Christopher | Direct Ownership | Common Stock | S - Open market or private sale | -12,053 | $14.11 |
Feb 21/24 | Feb 20/24 | Palleiko Benjamin L | Direct Ownership | Common Stock | S - Open market or private sale | -22,802 | $14.11 |
Feb 21/24 | Feb 20/24 | Audhya Paul K. | Direct Ownership | Common Stock | S - Open market or private sale | -14,295 | $14.12 |
Feb 21/24 | Feb 20/24 | Crockett Thomas Andrew | Direct Ownership | Common Stock | S - Open market or private sale | -24,888 | $14.11 |
Feb 21/24 | Feb 17/24 | Feener Edward P. | Direct Ownership | Performance Stock Units | M - Exercise or conversion exempt under rule 16b-3 | -7,292 | |
Sign up or login above to see all SEC filings within the past 6 months. |
Latest 10 SEC filings (by filing date) for KALV within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Mar 8/24 | Mar 6/24 | Palleiko Benjamin L | Direct Ownership | Restricted Stock Unit | A - Grant, award or other under Rule 16b-3(d) | 250,000 | |
Feb 22/24 | Feb 20/24 | Venrock Healthcare Capital Partners III, L.P. | Indirect Ownership | Pre-Funded Warrants (Right to Buy) | P - Open market or private purchase | 655,738 | $15.25 |
Feb 21/24 | Feb 17/24 | Feener Edward P. | Direct Ownership | Performance Stock Units | M - Exercise or conversion exempt under rule 16b-3 | -7,292 | |
Feb 21/24 | Feb 17/24 | Feener Edward P. | Direct Ownership | Performance Stock Units | M - Exercise or conversion exempt under rule 16b-3 | -7,292 | |
Feb 21/24 | Feb 17/24 | Feener Edward P. | Direct Ownership | Restricted Stock Unit | M - Exercise or conversion exempt under rule 16b-3 | -2,430 | |
Feb 21/24 | Feb 17/24 | Feener Edward P. | Direct Ownership | Restricted Stock Unit | M - Exercise or conversion exempt under rule 16b-3 | -1,774 | |
Feb 21/24 | Feb 20/24 | Feener Edward P. | Direct Ownership | Common Stock | S - Open market or private sale | -300 | $14.72 |
Feb 21/24 | Feb 20/24 | Feener Edward P. | Direct Ownership | Common Stock | S - Open market or private sale | -19,591 | $14.04 |
Feb 21/24 | Feb 20/24 | Feener Edward P. | Direct Ownership | Common Stock | S - Open market or private sale | -8,397 | $14.11 |
Feb 21/24 | Feb 17/24 | Feener Edward P. | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 18,788 | |
Sign up or login above to see all SEC filings within the past 6 months. |
Sign up or login above to see the past 6 months of filings sorted by insider. . |
Competitors with Recent Insider Filings |
Intra-Cellular Therapies (OQ:ITCI) |
Apellis Pharmaceuticals (OQ:APLS) |
Biomarin Pharmaceutical (OQ:BMRN) |